Founder of the Company. Involved in the provision of business, clinical, technical and logistical support to developers and manufacturers bringing their devices into European markets. Concentrating on getting things to happen. Terry is one of the Co-Founders of the Company along with Rob Petterson.
Dr. Dodge is a UK-based General Medical Practitioner. She achieved first-class honors B.Sc in 1982 and MB.BS. from London University Kings College in 1984. After undertaking a broad range of hospital-based positions in London and the North-East of England Dr. Dodge obtained Membership of the Royal College of General Practitioners and has practiced as a GP (Family Doctor) since.
Rachel is a Registered Nurse with additional University qualifications in prescribing and tissue viability, with over two decades experience in the medical device field. She was the Senior Nurse for mechanical circulatory support at the world-renowned Harefield Hospital in the UK, with management and budgetary responsibilities. Recently she was Principal Clinical & Medical Affairs Specialist at Medtronic, covering Europe, Middle East and Africa.
Dereck has had a distinguished career in the technical aspects of cardio-respiratory surgery and medicine. He developed a number of devices and techniques for Cardiopulmonary Bypass and was a member of the first UK Heart Transplant Unit, responsible for transplant logistics, organ preservation and various research activities. He was the first European consultant for an Artificial Heart technology company and went on to represent a number of companies, providing teaching, technical support and research as one of two partners in Circulation Technology; Assistant editor of the first international journal of Perfusion; part-time course instructor for the Engineering Dept. of Cambridge University and the recipient of 4 major research grants. Dereck had over 60 articles published in peer reviewed journals and contributed 10 book chapters to educational textbooks. He has a PhD – Organ Preservation for Heart Transplantation.
Andrew has a long experience managing multi-national companies. His role prior to joining FirstClinTech was as Company Secretary taking Sibir, a UK-listed Russian-owned oil and gas exploration venture, from start-up to an eventual $3.1 billion sale. He is a Chartered Accountant in the UK. Andrew is a member of the Board of Directors of the Company.